<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03922295</url>
  </required_header>
  <id_info>
    <org_study_id>1ORL</org_study_id>
    <nct_id>NCT03922295</nct_id>
  </id_info>
  <brief_title>Endoscopic Tympanoplasty: Single Versus Double Flap Technique</brief_title>
  <official_title>Endoscopic Tympanoplasty: Single Versus Double Flap Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to compare results of double and single flap techniques for
      tympanoplasty in chronic suppurative otitis media patients. Inclusion criteria include total
      or subtotal tympanic membrane perforations with limited anterior remnant and should be dry
      for at least 3 months. Patients with persistent discharge, cholesteatoma, ossicular affection
      or those with recurrent perforations after previous myringoplasty were excluded. Also,
      patients with uncontrolled diabetes, chronic liver and kidney diseases and immuno-compromised
      patients are not included in this study. Patients are divided into two groups, endoscopic
      double flap group and endoscopic single flap group. Healing and hearing outcomes were
      evaluated 3 months postoperative. Also, post-operative pain scores and complications were
      assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 24, 2017</start_date>
  <completion_date type="Actual">February 20, 2019</completion_date>
  <primary_completion_date type="Actual">February 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing or graft take rate</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>closure of tympanic membrane perforation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Tympanic Membrane Perforation</condition>
  <arm_group>
    <arm_group_label>endoscopic double flap group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>endoscopic single flap group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic tympanoplasty</intervention_name>
    <description>In the double flap group, graft is placed via elevation of both posterior and anterior flaps.
In the single flap group, graft is placed via elevation of posterior flap only</description>
    <arm_group_label>endoscopic double flap group</arm_group_label>
    <arm_group_label>endoscopic single flap group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic suppurative otitis media with total or subtotal tympanic
             membrane perforation with limited anterior remnant.

          -  dry perforation for at least 3 months.

        Exclusion Criteria:

          -  Recurrent perforation after previous myringoplasty.

          -  Ossicular disruption or fixation.

          -  immune-compromised patients including uncontrolled diabetics, chronic liver and kidney
             diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noha A Elkholy</last_name>
    <role>Principal Investigator</role>
    <affiliation>ORL-HNS department, Faculty of Medicine, Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammed A Salem</last_name>
    <role>Study Director</role>
    <affiliation>ORL-HNS department, Faculty of Medicine, Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdelwahab M Rakha</last_name>
    <role>Study Chair</role>
    <affiliation>ORL-HNS department, Faculty of Medicine, Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ORL-HNS department,Mansoura University Hospital, Faculty of Medicine, Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <state>ElDakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>September 6, 2019</last_update_submitted>
  <last_update_submitted_qc>September 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Noha A.Elkholy</investigator_full_name>
    <investigator_title>ORL-HNS Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tympanic Membrane Perforation</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/95/NCT03922295/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

